SEC Form 4 · accession 0001179110-18-003787
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon J Bracken
Officer — Senior Vice President
Period of report
Mar 5, 2018
Accepted (ET)
Mar 7, 2018 · 5:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Mar 5, 2018 | S | 1,600 | $60.267 | D | 44,790 | D | |
| Common shares without par value | Mar 5, 2018 | S | 200 | $60.265 | D | 44,590 | D | |
| Common shares without par value | Mar 5, 2018 | S | 300 | $60.261 | D | 44,290 | D | |
| Common shares without par valueF1 | holding | — | — | — | 747 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of March 5, 2018.